Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by de Geest, N.
Right arrow Articles by d'Azzo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Geest, N.
Right arrow Articles by d'Azzo, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2002, Vol. 11, No. 12 1455-1464
© 2002 Oxford University Press

Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice

Natalie de Geest, Erik Bonten, Linda Mann, Jean de Sousa-Hitzler, Christopher Hahn{dagger} and Alessandra d'Azzo*

Department of Genetics, St Jude Children's Research Hospital, Memphis, TN 38105, USA

Received February 18, 2002; Accepted March 27, 2002

Neuraminidase initiates the hydrolysis of sialo-glycoconjugates by removing their terminal sialic acid residues. In humans, primary or secondary deficiency of this enzyme leads to two clinically similar neurodegenerative lysosomal storage disorders: sialidosis and galactosialidosis (GS). Mice nullizygous at the Neu1 locus develop clinical abnormalities reminiscent of early-onset sialidosis in children, including severe nephropathy, progressive edema, splenomegaly, kyphosis and urinary excretion of sialylated oligosaccharides. Although the sialidosis mouse model shares clinical and histopathological features with GS mice and GS patients, we have identified phenotypic abnormalities that seem specific for sialidosis mice. These include progressive deformity of the spine, high incidence of premature death, age-related extramedullary hematopoiesis, and lack of early degeneration of cerebellar Purkinje cells. The differences and similarities identified in these sialidosis and GS mice may help to better understand the pathophysiology of these diseases in children and to identify more targeted therapies for each of these diseases.

* To whom correspondence should be addressed at: Department of Genetics, St Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA. Tel:+1901 495 2698; Fax:+1901 526 2907; Email: sandra.dazzo{at}stjude.org

{dagger} Present address: Christopher Hahn, Vascular Biology Laboratory, Hanson Centre for Cancer Research, Adelaide, Australia 5000


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
V. Seyrantepe, M. Canuel, S. Carpentier, K. Landry, S. Durand, F. Liang, J. Zeng, A. Caqueret, R. A. Gravel, S. Marchesini, et al.
Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage
Hum. Mol. Genet., June 1, 2008; 17(11): 1556 - 1568.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hinek, A. V. Pshezhetsky, M. von Itzstein, and B. Starcher
Lysosomal Sialidase (Neuraminidase-1) Is Targeted to the Cell Surface in a Multiprotein Complex That Facilitates Elastic Fiber Assembly
J. Biol. Chem., February 10, 2006; 281(6): 3698 - 3710.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y.-H. Xu, B. Quinn, D. Witte, and G. A. Grabowski
Viable Mouse Models of Acid {beta}-Glucosidase Deficiency: The Defect in Gaucher Disease
Am. J. Pathol., November 1, 2003; 163(5): 2093 - 2101.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.